Futuresinfocus

100M Americans have pre-diabetes conditions, one of the leading causes of death. By 2032 over half a billion people on Earth will have it globally. If it is 25% of US health dollars and healthcare is fifteen percent of the US economy, then imagine the size of the economic impact of not solving this globally by 2032 and beyond. It would be in the trillions, the size of many large European economies combined. Finding ways to solve or reduce the speed of this disease should be a significant priority for us. This is a discussion with Robert Booth, Glytec’s chief strategy and research officer, about how to reduce that by 2032 radically.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.